Home Compare BSX vs SYK
Stock Comparison · Industry comparison · Medical Devices

Boston Scientific vs Stryker: Which Stock Looks Stronger in 2026?

Stryker holds the cleaner structural position, with the lead spread across profitability and stability. Boston Scientific still has the edge on growth, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in profitability, with stability adding a second layer of support.

INDUSTRY COMPARISON

Both operate in: Medical Devices

This comparison is based on industry proximity, not on functional trajectory similarity. BSX and SYK share the same industry classification.

For a similarity-based comparison, see how Boston Scientific and Stryker each position within their functional peer groups in AssetNext.

Peer-Relative Score
BSX
Boston Scientific Corporation
55
Peer-Score
Signal qualityHigh
vs
SYK
Stryker Corporation
61
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BSX vs SYK Profitability 37 61 Stability 59 71 Valuation 52 47 Growth 83 72 BSX SYK
Gap Ranking
#1 Profitability +24
#2 Stability +12
#3 Growth +11
#4 Valuation +5
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BSX and SYK Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BSXSYK Relative valuation Structural strength

The setup remains mixed because the stronger profile and the more supportive price setup do not sit on the same side.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Stryker Corporation sits in the stronger part of the group on profitability, while Boston Scientific Corporation is closer to mid-pack.
Stability
Both look solid on stability, though Stryker Corporation still holds the stronger peer position.
Profitability — Dominant Gap
BSX
37
SYK
61
Gap+24in favour of SYK

The profitability lead is mainly driven by a 7.5-point operating margin advantage.

What keeps the gap from being one-sided

Growth still leans toward Boston Scientific Corporation, so the lead is real without reading as one-way.

What this means for the comparison

The lead is built on both profitability and stability — though growth still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the BSX vs SYK comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-and-stability comparisons

Explore how BSX and SYK each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.